| Issue |
Title |
File |
| Vol 7, No 3 (2010) |
Epidemiologicheskaya kharakteristika rezistentnoy i nekontroliruemoy arterial'noy gipertenzii v Rossiyskoy Federatsii(Rossiyskiy registr nekontroliruemoy i rezistentnoy arterial'noy gipertenzii REGATA-PRIMA «REzistentnaya Gipertoniya ArTeriAl'naya - PRichiny I Mekhanizmy rAzvitiya») |
|
|
Chazova I.E., Fomin V.V., Razuvaeva M.A., Vigdorchik A.V.
|
| Vol 2, No 1 (2005) |
Epidemiologiya insul'ta v Rossiyskoy Federatsii |
|
|
Skvortsova V.I., Stakhovskaya L.V., Ayriyan N.Y.
|
| Vol 13, No 3 (2016) |
Ethnogenetic aspects of obesity and disorders of carbohydrate metabolism as a risk factor of arterial hypertension |
(Rus)
|
|
Mulerova T.A., Tsygankova D.P., Voropaeva E.N., Maksimov V.N., Ogarkov M.Y.
|
| Vol 18, No 1 (2021) |
Etiopathogenesis, diagnosis, and approaches to the treatment of arterial hypertension: an assessment of the physicians’ basic knowledge. Final results of the PHYSTARH project |
(Rus)
|
|
Bontsevich R.A., Vovk Y.R., Gavrilova A.A., Kirichenko A.A., Ebzeeva E.Y., Kosmacheva E.D., Kompaniets O.G., Prozorova G.G., Nevzorova V.A., Martynenko I.M., Barysheva V.O., Ketova G.G., Maksimov M.L., Osipova O.A.
|
| Vol 13, No 2 (2016) |
Evaluating of the effectiveness and safety of the reproduced selective β1-blocker without intrinsic sympathomimetic activity Bidop® in patients with hypertrophic cardiomyopathy |
(Rus)
|
|
Feiskhanova L.I., Malov A.A.
|
| Vol 16, No 2 (2019) |
Evaluation of compliance of pulmonary hypertension patients to the treatment with inhaled iloprost (Ventavis): results of prospective, multicenter, non-interventional IVENT study |
(Rus)
|
|
Martynyuk T.V.
|
| Vol 15, No 4 (2018) |
Evaluation of effectiveness and safety of the first Russian-manufactured generic bosentan use in patients with pulmonary arterial hypertension |
(Rus)
|
|
Arkhipova O.A., Gratsianskaya S.E., Martynyuk T.V.
|
| Vol 18, No 3 (2021) |
Evaluation of heart rate variability in patients with different forms of pulmonary hypertension |
(Rus)
|
|
Qurbonbekova N.K., Kasparova A.M., Kozhemyakina E.S., Sobolev A.V., Martynyuk T.V.
|
| Vol 15, No 4 (2018) |
Evaluation of subclinical cardiotoxicity in patients with breast cancer and arterial hypertension in two regimens of anthracycline-containing chemotherapy |
(Rus)
|
|
Avalyan A.A., Oshchepkova E.V., Saidova M.A., Shitov V.N., Glazkova E.V., Stenina M.B., Chazova I.E.
|
| Vol 10, No 1 (2013) |
Evaluation of the antihypertensive efficacy and safety of moxonidine in the treatment of uncomplicated hypertensive crisis |
|
|
Tereshchenko S.N., Gaponova N.I., Abdrakhmanov V.R.
|
| Vol 17, No 1 (2020) |
Evidence base regarding target levels of arterial pressure in patients after a stroke: focus on a geriatric population |
(Rus)
|
|
Ostroumova O.D., Cherniaeva M.S.
|
| Vol 16, No 3 (2019) |
Experience of the management of patients with pulmonary hypertension in the Republic of Karelia |
(Rus)
|
|
Ryabkov V.A., Vezikova N.N., Malygin A.N., Novozhilova N.V., Merenkov V.V.
|
| Vol 11, No 1 (2014) |
Experience of treating hypertension in an outpatient setting: a clinical case |
(Rus)
|
|
Agafonov A.N., Khozyainova N.Y., Petruschenkova O.V.
|
| Vol 18, No 1 (2021) |
Expert consensus. Effect of antihypertensive therapy on cognitive functions |
(Rus)
|
|
Ostroumova O.D., Parfenov V.A., Ostroumova T.M., Yakhno N.N., Chazova I.E., Bogolepova A.N., Galyavich A.S., Geraskina L.A., Emelin A.I., Zakharov V.V., Kislyak O.A., Kulesh A.A., Levin O.S., Podzolkov V.I., Privalova E.V., Shikh E.V.
|
| Vol 12, No 3 (2015) |
Experts of RMSAH opinion: the fixed combination of azilsartan medoxomil and chlortalidone is broadening options of the combined therapyin patients with arterial hypertension |
(Rus)
|
|
Chazova I.E., Karpov Y.A., Chukaeva I.I., Kislyak O.A., Zhernakova Y.V., Martynuk T.V., Litvin A.Y.
|
| Vol 10, No 2 (2013) |
Factors influencing compliance with lifestyle modification in an organized population |
|
|
Alekseeva T.S., Ogarkov M.Y., Skripchenko A.E., Yankin M.Y.
|
| Vol 10, No 3 (2013) |
Farmakologicheskaya blokada angiotenzinovykh retseptorov v lechenii arterial'noy gipertenzii: ot saralazina do sartanov |
|
|
Fomin V.V., Svistunov A.A.
|
| Vol 8, No 4 (2011) |
Farmakoterapiya arterial'noy gipertenzii v menopauze. Vzaimosvyazi arterial'noy gipertenzii i disfunktsii endoteliya u zhenshchin v menopauze, vozmozhnosti ikh korrektsii |
|
|
Dorofeeva G.B., Dorofeev V.I., Trofimova Y.V., Dzhioeva E.K., Manerova O.V.
|
| Vol 15, No 4 (2018) |
Features of antihypertensive and vasoprotective efficiency of combination of valsartan and amlodipine in patients with obesity under different polymorphic variants of CYP2C9 and CYP11B2 genes |
(Rus)
|
|
Kovalenko F.A., Skibitsky V.V., Fendrikova A.V.
|
| Vol 16, No 3 (2019) |
Features of arterial hypertension patients with discrepancies in vectorcardiographic and echocardiographic conclusions about the presence of left ventricular hypertrophy [Original Article] |
(Rus)
|
|
Blinova E.V., Sakhnova T.A., Chaykovskaya O.Y., Saidova M.A., Ryabykina G.V.
|
| Vol 13, No 2 (2016) |
Features of cardiac remodeling in patients with hypertension of different ethnic groups |
(Rus)
|
|
Abramov E.A., Nevzorova V.A., Repina N.I.
|
| Vol 17, No 2 (2020) |
Features of cerebral autoregulation and reactivity in patients with arterial hypertension in older age groups with orthostatic hypotensive reactions |
(Rus)
|
|
Atyunina I.V., Oshchepkova E.V., Rogoza A.N.
|
| Vol 13, No 3 (2016) |
Features of cutaneous microcirculatory blood flow in patients with pulmonary hypertension of different etiology |
(Rus)
|
|
Dolgova E.V., Fedorovich A.A., Martynyuk T.V., Rogoza A.N., Chazova I.E.
|
| Vol 15, No 3 (2018) |
Features of diurnal blood pressure profile, arterial stiffness and left ventricular structure and function in patients with arterial hypertension, prediabetes and type 2 diabetes mellitus |
(Rus)
|
|
Fendrikova A.V., Gutova S.R., Skibitsky V.V., Skibitsky A.V.
|
| Vol 14, No 4 (2017) |
Features of the use of torasemide in arterial hypertension |
(Rus)
|
|
Baryshnikova G.A., Chorbinskajya S.A.
|
| Vol 12, No 2 (2015) |
Fibromuscular dysplasia as the cause of malignant renovascular hypertension in a newborn |
(Rus)
|
|
Albot V.V., Dolgikh V.V., Gvak G.V., Pogodina A.V.
|
| Vol 5, No 3 (2008) |
Fiksirovannaya kombinatsiya amlodipina i valsartana: komu zhe ona neobkhodima v pervuyu ochered'? |
|
|
Lopatin Y.M.
|
| Vol 9, No 2 (2012) |
Fiksirovannaya kombinatsiya b-blokatora i diuretika u patsientov s arterial'noy gipertoniey vysokogo riska |
|
|
Chazova I.E., Ratova L.G.
|
| Vol 7, No 4 (2010) |
Fiksirovannaya kombinatsiya -blokatora i diuretika v lechenii bol'nykh arterial'noy gipertoniey |
|
|
Chazova I.E., Ratova L.G.
|
| Vol 8, No 3 (2011) |
Fiksirovannaya kombinatsiya ingibitoraangiotenzinprevrashchayushchego fermentai antagonista kal'tsiya v lecheniibol'nykh arterial'noy gipertenziey |
|
|
Chazova I.E., Ratova L.G., Nedogoda S.V., Lopatin Y.M., Perepech N.B., Tsoma V.V.
|
| Vol 4, No 2 (2007) |
Fiksirovannaya kombinatsiya perindoprila i indapamida u patsientov s arterial'noy gipertenziey v usloviyakh real'noy klinicheskoy praktiki |
|
|
Kolos I.P., Martynyuk T.V., Chazova I.E.
|
| Vol 8, No 1 (2011) |
Fiksirovannaya kombinatsiya valsartana i amlodipina v lechenii rezistentnoy i nekontroliruemoy arterial'noy gipertenzii (Rossiyskiyregistr nekontroliruemoy i rezistentnoy arterial'noy gipertenzii REGATA-EKSTRA «REzistentnaya Gipertoniya ArTeriAl'naya - EKSforzh vTerapii Rezistentnoy Arterial'noy gipertenzii»). |
|
|
Chazova I.E., Fomin V.V., Razuvaeva M.A., Vigdorchik A.V.
|
| Vol 5, No 2 (2008) |
Fiksirovannye kombinatsii - optimal'naya strategiya lecheniya patsientov s arterial'noy gipertenziey. Novaya kombinatsiya b-blokatora i diuretika - Lodoz |
|
|
Ostroumova O.D., Srednyakov A.V., Guseva T.F.
|
| Vol 8, No 1 (2011) |
Fiksirovannye kombinatsii antigipertenzivnykh preparatov kak sposob povysheniya effektivnosti lecheniya bol'nykh arterial'noygipertenziey. Rezul'taty programmy IRISY (IRuzid®. Izuchenie effektivnoSti lecheniya u bol'nYkh arterial'noy gipertenziey v usloviyakhstatsionara). |
|
|
Ratova L.G., Chazova I.E.
|
| Vol 6, No 1 (2009) |
Final results of STRATEGYA Study (Russian Comparative Programme on a fixed,low-dose perindopril/indapamide combination efficacy in hypertensive patients with inadequateblood pressure control): use of a fixed, low- dose perindopril/indapamide combination in hypertensivepatients in real clinical practice |
|
|
Martynyuk T.V., Kolos I.P., Chazova I.E., Martyniuk T.V., Kolos I.P., Chazova I.E.
|
| Vol 17, No 2 (2020) |
First results of Russian multicenter prospective clinical study VICTORY II: Vamloset® and Co-Vamloset effectiveness and safety in patients with stage 2 and 3 arterial hypertension |
(Rus)
|
|
Chazova I.E., Martynyuk T.V., Rodnenkov V.O., Gorieva B.S., Rogoza A.N., Arkhipov M.V., Grinshtein Y.I., Ostroumova O.D., Galiavich A.S., Rotar’ O.P., Haisheva L.A., Kameneva T.R.
|
| Vol 11, No 4 (2014) |
First results of the Russian database of international prospective observational registry variability of blood pressure in patients with hypertension |
(Rus)
|
|
Ostroumova O.D.
|
| Vol 15, No 1 (2018) |
Fixed combination of amlodipine and lisinopril effectiveness in hypertensive smokers |
(Rus)
|
|
Ostroumova O.D., Kochetkov A.I.
|
| Vol 14, No 1 (2017) |
Fixed combination of highly selective β-adrenoblocker bisoprolol and calcium antagonist amlodipine (Concor® AM) for arterial hypertension treatment in metabolic disorder patients |
(Rus)
|
|
Zhernakova Y.V., Martyniuk T.V., Arkhipova O.A., Azimova M.O., Rogoza A.N., Chazova I.E.
|
| Vol 12, No 3 (2015) |
Fixed dose combinations for the treatment arterial hypertension: the real way to improve control |
(Rus)
|
|
Morozova T.E., Andreev S.S.
|
| Vol 6, No 4 (2009) |
Fleita is a Russian randomized, open-label, multicenter, comparative program for the evaluation of the efficacy and safety of the fixed combination drug Tarka (ABBOTT Laboratories, USA) versus optional sustained-release antihypertensive drugs in the treatment of patients with arterial hypertension and cognitive disorders (stepwise strategy) |
|
|
Chazova I.E., Ostroumova O.D.
|
| Vol 12, No 4 (2015) |
From the choice of antihypertensive drug to the choice of fixed combinations of antihypertensive drugs: a paradigm shift |
(Rus)
|
|
Ostroumova O.D., Bondarets O.V., Kopchenov I.I., Guseva T.F.
|
| Vol 12, No 1 (2015) |
Functional state of kidneys and arterial hypertension among indigenous and nonindigenous residents of Mountain Shoria |
(Rus)
|
|
Ogarkov M.Y., Filimonov E.S., Mulerova T.A., Kuzmina A.A.
|
| Vol 6, No 1 (2009) |
Functional state of retina - criterion of efficacy antihypertensive therapy |
|
|
Adasheva T.V., Zadionchenko V.S., Shamshinova A.M., Arakelyan M.A., Adasheva T.V., Zadionchenko V.S., Shamshinova A.M., Arakelian M.A.
|
| Vol 3, No 2 (2006) |
Funktsiya endoteliya i narushenie regulyatsii mozgovogo krovotoka u bol'nykh arterial'noy gipertenziey i vozmozhnosti ikh korrektsii tiazidopodobnym diuretikom indapamidom retard 1,5 mg |
|
|
Morgunov M.N., Kastanayan A.A., Nelasov N.Y.
|
| Vol 16, No 3 (2019) |
Gender characteristics of obstructive sleep apnea syndrome clinical manifestations and patients' quality of life |
(Rus)
|
|
Khachatryan N.T., Elfimova E.M., Mikhailova O.O., Litvin A.Y., Chazova I.E.
|
| Vol 15, No 3 (2018) |
Gender differences efficiency of various dosage regimes of antihypertensive agents by patients with arterial hypertension and coronary heart disease |
(Rus)
|
|
Skibitsky V.V., Gorodetskaya E.V., Kudryashov E.A., Fendrikova A.V., Skibitsky A.V.
|
| Vol 12, No 3 (2015) |
Gender differences renin-angiotensin-aldosterone system and its relation to humoral factors in patients with arterial hypertension |
(Rus)
|
|
Dadashova G.M.
|
| Vol 17, No 4 (2020) |
Gender-age peculiarities of smoking and diabetes mellitus role in the development of myocardial infarction in patients with arterial hypertension |
(Rus)
|
|
Aksenova A.V., Oshchepkova E.V., Orlovsky A.A., Chazova I.E.
|
| Vol 8, No 2 (2011) |
Gendernye osobennosti kontsentratsiileptina i vnutripochechnoygemodinamiki u bol'nykhessentsial'noy arterial'noygipertenziey i ozhireniem |
|
|
Podzolkov V.I., Bragina A.E., Rodionova Y.N.
|
| Vol 9, No 2 (2012) |
Gendernye razlichiya effektivnosti gipotenzivnoy terapii: lozartan i enalapril |
|
|
Tarlovskaya E.I., Suvorova D.A., Sobolev A.A.
|
| Vol 1, No 2 (2004) |
Gipertonicheskie krizy, sovremennye printsipy terapii |
|
|
Tereshchenko S.N.
|
| Vol 1, No 1 (2004) |
Gipotenzivnaya effektivnost' novoy lekarstvennoy formy metoprolola zamedlennogo vysvobozhdeniya u bol'nykh s arterial'noy gipertoniey |
|
|
Belousov Y.B., Leonova M.V., Erofeeva S.B.
|
| Vol 13, No 2 (2016) |
"Grey zone" of vasoreactivity during acute vasodilator testing in patients with pulmonary hypertension |
(Rus)
|
|
Sagaydak O.V., Danilov N.M., Matchin Y.G., Martynyuk T.V., Chazova I.E.
|
| Vol 15, No 3 (2018) |
Guidelines for diagnostics and treatment of hypertension 2018 - European experts’opinion [Guidelines] |
(Rus)
|
|
Chazova I.E., Zhernakova Y.V.
|
| Vol 17, No 1 (2020) |
Guidelines on treatment of patients with arterial hypertension comorbid with metabolic disorders and diabetes mellitus type 2 |
(Rus)
|
|
Chazova I.E., Shestakova M.V., Zhernakova Y.V., Markova T.N., Mazurina N.V., Yezhov M.V., Mironova O.Y., Litvin A.Y., Elfimova E.M., Blinova N.V., Sukhareva O.Y., Ametov A.S., Akhmedzhanov N.M., Kislyak O.A., Kukharchuk V.V., Nedogoda S.V., Nebieridze D.V., Medvedev I.V., Mkrtumyan A.M., Podzolkov V.I.
|
| Vol 12, No 2 (2015) |
Heart rate in patients with arterial hypertension:a possible marker of high risk or independent therapeutic target? |
(Rus)
|
|
Kobalava Z.D., Shavarova E.K.
|
| Vol 16, No 4 (2019) |
Heart rate variability in women with essential hypertension under exposure of regular moderate physical training |
(Rus)
|
|
Smolyakov Y.N., Kuznik B.I., Guseva E.S., Davydov S.O.
|
| Vol 6, No 1 (2009) |
Hyperfiltration and metabolic syndrome |
|
|
Arutyunov G.P., Oganezova L.G., Arutyunov G.P., Oganezova L.G.
|
| Vol 6, No 4 (2009) |
Hypertension Summer School 19-25 September, 2009 - Smolenice, Slovakia |
|
|
Aksenova A.V.
|
| Vol 11, No 1 (2014) |
Hypertension treatment features in perimenopausal women |
(Rus)
|
|
Zhernakova Y.V., Chazova I.E.
|
| Vol 10, No 1 (2013) |
Hypertension treatment: Is there a place for b-adrenoblockers? |
|
|
Minushkina L.O.
|
| Vol 15, No 2 (2018) |
Hypertensive crisis as cerebrovascular disease risk factor |
(Rus)
|
|
Kravchenko M.A., Andreeva O.S., Gnedovskaya E.V., Chechetkin A.O., Varakin Y.Y., Oshchepkova E.V., Piradov M.A.
|
| Vol 6, No 2 (2009) |
HYVET: landmark trial voted 2008 Trialof the Year by the ImpACT/Society for Clinical Trials and the American Heart Association |
|
|
- -.
|
| Vol 8, No 4 (2011) |
Iloprost - ingalyatsionnyy analog prostatsiklina dlya lecheniya bol'nykh legochnoy gipertenziey |
|
|
Martynyuk T.V., Chazova I.E.
|
| Vol 9, No 4 (2012) |
Iloprost for acute tests in patients with pulmonary arterial hypertension |
|
|
Belyatko E.A., Danilov N.M., Matchin Y.G., Martynyuk T.V., Chazova I.E.
|
| Vol 15, No 1 (2018) |
Immune alterations and endothelial dysfunction in patients with hand-arm vibration syndrome comorbid with hypertension |
(Rus)
|
|
Babanov S.A., Baraeva R.A., Budash D.S., Baykova A.G.
|
| Vol 17, No 4 (2020) |
Impact of metabolic syndrome parameters and different fat depots on arterial stiffness in patients with abdominal obesity |
(Rus)
|
|
Andreevskaia M.V., Zheleznova E.A., Zhernakova J.V., Chazova I.E., Shariia M.A., Blinova N.V., Zairova A.R., Azimova M.O., Rogoza A.N., Saidova M.A.
|
| Vol 17, No 3 (2020) |
Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II |
(Rus)
|
|
Chazova I.E., Martynyuk T.V., Rodnenkov O.V., Gorieva S.B., Rogoza A.N., Arkhipov M.V., Grinshtein Y.I., Ostroumova O.D., Galiavich A.S., Rotar’ O.P., Khaisheva L.A., Kameneva T.R.
|
| Vol 15, No 2 (2018) |
Improving blood pressure control, organoprotection and metabolic disorders correction in patients with hypertension switching from diuretic-based combinations to fixed combination lisinopril + amlodipine + rosuvastatin |
(Rus)
|
|
Nedogoda S.V., Chumachek E.V., Ledyaeva A.A., Tsoma V.V., Salasyuk A.S., Smirnova V.O., Khripaeva V.Y., Palashkin R.V., Popova E.A.
|
| Vol 15, No 3 (2018) |
Influence of allure polymorphism distribution of arterial hypertensions gene-candidates jointly with cardiovascular risk factors on change of thickness of intima-media complex among patients with higher arterial pressure living in Mountain Shoriya |
(Rus)
|
|
Mulerova T.A., Maksimov S.A., Chigisova A.N., Ogarkov M.Y.
|
| Vol 12, No 2 (2015) |
Influence of metabolic syndrome components on the level of nitric oxide stable metabolites in patients with essential hypertension |
(Rus)
|
|
Podzolkov V.I., Bragina A.E., Bragina G.I., Murashko N.A.
|
| Vol 7, No 3 (2010) |
Informatsionnoe pis'mo Rossiyskogo meditsinskogo obshchestva po arterial'noy gipertonii.Ekspertnyy sovet «Perspektivy primeneniya novogo preparata Prestans» |
|
|
Chazova I.E.
|
| Vol 9, No 1 (2012) |
Ingalyatsionnyy oksid azota u patsientov s idiopaticheskoy legochnoy gipertenziey: rezul'taty pilotnogo issledovaniya |
|
|
Konosova I.D., Martynyuk T.V., Chazova I.E.
|
| Vol 4, No 1 (2007) |
Ingibitory angiotenzinprevrashchayushchego fermenta |
|
|
Ostroumova O.D., Guseva T.F., Smolyarchuk E.A., Zhukova O.V.
|
| Vol 5, No 1 (2008) |
Ingibitory angiotenzinprevrashchayushchego fermenta v ostrom periode infarkta miokarda: uroki issledovaniya SMILE |
|
|
Ostroumova O.D.
|
| Vol 5, No 2 (2008) |
Ingibitory angiotenzinprevrashchayushchego fermenta v terapii arterial'noy gipertonii: pleyotropnye effekty i dopolnitel'nye klinicheskie preimushchestva |
|
|
Adasheva T.V., Zadionchenko V.S., Matsievich M.V.
|
| Vol 7, No 3 (2010) |
Ingibitory angiotenzinprevrashchayushchego fermenta: znachimy li imeyushchiesya razlichiya dlya kliniki? |
|
|
Kirichenko A.A.
|
| Vol 14, No 3 (2017) |
Interaction of antihypertensive drugs and rosuvastatin: focus on safety, efficiency and prospects |
(Rus)
|
|
Luchinina E.V., Kompaniets O.G., Kizhvatova N.V.
|
| Vol 9, No 3 (2012) |
Ispol'zovanie fiksirovannykh kombinatsiy antigipertenzivnykh sredstv - panatseya v snizhenii serdechno-sosudistykh oslozhneniy? |
|
|
Ostroumova O.D., Guseva T.F., Bondarets O.V.
|
| Vol 8, No 1 (2011) |
Ispol'zovanie rozuvastatina v lechenii bol'nykh gruppy riska sosudistykh oslozhneniy ateroskleroza. |
|
|
Zateyshchikov D.A.
|
| Vol 10, No 3 (2013) |
Izuchenie kognitivnykh funktsiy mozga u bol'nykh arterial'noy gipertoniey s nalichiem ili otsutstviem metabolicheskogo sindroma |
|
|
Sharipova G.K., Chazova I.E., Zhernakova Y.V.
|
| Vol 10, No 3 (2013) |
K yubileyu Yuriya Petrovicha Nikitina |
|
|
- -.
|
| Vol 8, No 3 (2011) |
K yubileyuIriny Evgen'evny Chazovoy |
|
|
- -.
|
| Vol 4, No 1 (2007) |
Kak dostich' garmonii v lechenii arterial'noy gipertonii |
|
|
Chazova I.E., Ratova L.G.
|
| Vol 2, No 2 (2005) |
Kal'tsievye blokatory v profilaktike insul'ta |
|
|
Drapkina O.M.
|
| Vol 7, No 2 (2010) |
Kardioprotektivnye svoystva blokatorov retseptorov angiotenzina II: fokus na lozartan |
|
|
Morozova T.E., Andrushchishina T.B.
|
| Vol 8, No 3 (2011) |
Kardiorenal'nyyi neyrogormonal'nyy kontinuumu bol'nykh arterial'noygipertenziey, ego znacheniev klinicheskoy praktike |
|
|
Akhadov S.V., Ruzbanova G.R., Molchanova G.S., Talalaeva T.G., Khoreva S.N., Akhadova A.S.
|
| Vol 8, No 3 (2011) |
Klinicheskaya farmakologiya sartanov:klass-effekt i farmakodinamicheskieosobennosti preparatov |
|
|
Zakharova N.V., Kuz'mina-Krutetskaya S.R.
|
| Vol 3, No 1 (2006) |
Klinicheskaya i ekonomicheskaya effektivnost' lecheniya arterial'noy gipertenzii v usloviyakh statsionara: fokus na polnodozovye kombinatsii |
|
|
Ostroumova O.D., Golovina O.V., Zhukova O.V., Sklyarova N.V., Bondarets O.V., Paukov S.V.
|
| Vol 5, No 4 (2008) |
Klinicheskie proyavleniya porazheniya serdechno-sosudistoy sistemy pri nespetsificheskom aortoarteriite |
|
|
Chikhladze N.M., Sivakova O.A., Chazova I.E.
|
| Vol 5, No 2 (2008) |
klinicheskiy sluchay Arterial'naya gipertoniya u bol'nykh nespetsificheskim aortoarteriitom s porazheniem pochechnykh arteriy |
|
|
Chikhladze N.M., Sivakova O.A., Gaman S.A., Andreevskaya M.V., Kharlap G.V., Kul'bak V.A., Burtseva E.A., Golavyuk A.L., Zotikov A.E., Pokrovskiy A.V., Sinitsin V.E., Chazova I.E.
|
| Vol 3, No 2 (2006) |
Klinicheskiy sluchay: primenenie alprostadila pri lechenii bol'noy s idiopaticheskoy (pervichnoy) legochnoy gipertenziey |
|
|
Matvienko O.O., Martynyuk T.V., Danilov N.M., Lazutkina V.K., Ataullakhanova D.M., Chazova I.E.
|
| Vol 5, No 3 (2008) |
Klinicheskiy sluchay: primenenie postoyannogo polozhitel'nogo davleniya v dykhatel'nykh putyakh pri sindrome obstruktivnogo apnoe sna |
|
|
Galitsin P.V., Litvin A.Y., Aksenova A.V., Bolotova M.N., Sukmarova Z.N., Chazova I.E.
|
| Vol 5, No 1 (2008) |
Klinicheskiy sluchay: primenenie selektivnogo antagonistaretseptorov endotelina ambrizentana pri idiopaticheskoy legochnoy gipertenzii |
|
|
Andreeva Y.A., Martynyuk T.V., Ataullakhanova D.M., Lazutkina V.K., Korobkova I.Z., Sakhnova T.A., Blinova E.V., Danilov N.M., Nakonechnikov S.N., Chazova I.E.
|
| Vol 2, No 1 (2005) |
Klinicheskoe znachenie disfunktsii endoteliya pri arterial'noy gipertonii |
|
|
Nebieridze D.V.
|
| Vol 7, No 1 (2010) |
Kliniko-geneticheskie faktory riska razvitiya mikroal'buminurii pri arterial'noy gipertenzii |
|
|
Kuznetsova T.Y., Gavrilov D.V., Samokhodskaya L.M., Postnov A.Y., Boytsov S.A.
|
| Vol 5, No 1 (2008) |
KLIP-AKKORD: 4 goda i 7796 patsientov - vozmozhnosti polnodozovoy kombinirovannoy terapii arterial'noy gipertonii |
|
|
Chazova I.E., Ratova L.G.
|
| Vol 4, No 2 (2007) |
KLIP-AKKORD: lechim patsientov s umerennoy i tyazheloy arterial'noy gipertoniey |
|
|
Chazova I.E., Ratova L.G.
|
| Vol 18, No 4 (2021) |
Knowledge of senior students in the definition, classification, and approaches to the treatment of arterial hypertension. Final results of the PHYSTARH project |
(Rus)
|
|
Bontsevich R.A., Vovk Y.R., Gavrilova A.A., Batishcheva G.A., Goncharova N.I., Elizarova I.O., Ketova G.G., Barysheva V.O., Bikkinina G.M., Myronenko O.V.
|
| 201 - 300 of 734 Items |
<< < 1 2 3 4 5 6 7 8 > >> |
